These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 27233474)
1. Progesterone receptor activation is required for folic acid-induced anti-proliferation in colorectal cancer cell lines. Kuo CT; Lee WS Cancer Lett; 2016 Aug; 378(2):104-10. PubMed ID: 27233474 [TBL] [Abstract][Full Text] [Related]
2. Folic acid inhibits colorectal cancer cell migration. Ting PC; Lee WR; Huo YN; Hsu SP; Lee WS J Nutr Biochem; 2019 Jan; 63():157-164. PubMed ID: 30393128 [TBL] [Abstract][Full Text] [Related]
3. Activation of progesterone receptor is essential for folic acid-regulated cancer cell proliferation and migration. Wang HC; Huo YN; Lee WS J Nutr Biochem; 2023 Feb; 112():109205. PubMed ID: 36455835 [TBL] [Abstract][Full Text] [Related]
4. Folic acid inhibits endothelial cell proliferation through activating the cSrc/ERK 2/NF-κB/p53 pathway mediated by folic acid receptor. Lin SY; Lee WR; Su YF; Hsu SP; Lin HC; Ho PY; Hou TC; Chou YP; Kuo CT; Lee WS Angiogenesis; 2012 Dec; 15(4):671-83. PubMed ID: 22843228 [TBL] [Abstract][Full Text] [Related]
5. Folic acid inhibits COLO-205 colon cancer cell proliferation through activating the FRα/c-SRC/ERK1/2/NFκB/TP53 pathway: in vitro and in vivo studies. Kuo CT; Chang C; Lee WS Sci Rep; 2015 Jun; 5():11187. PubMed ID: 26056802 [TBL] [Abstract][Full Text] [Related]
6. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone. Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480 [TBL] [Abstract][Full Text] [Related]
7. Folic acid prevents the progesterone-promoted proliferation and migration in breast cancer cell lines. Wang HC; Huo YN; Lee WS Eur J Nutr; 2020 Sep; 59(6):2333-2344. PubMed ID: 31502059 [TBL] [Abstract][Full Text] [Related]
8. Folic acid inhibits endothelial cell migration through inhibiting the RhoA activity mediated by activating the folic acid receptor/cSrc/p190RhoGAP-signaling pathway. Hou TC; Lin JJ; Wen HC; Chen LC; Hsu SP; Lee WS Biochem Pharmacol; 2013 Feb; 85(3):376-84. PubMed ID: 23178654 [TBL] [Abstract][Full Text] [Related]
9. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway. Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813 [TBL] [Abstract][Full Text] [Related]
10. Effects of female sex hormones on folic acid-induced anti-angiogenesis. Lee WS; Lu YC; Kuo CT; Chen CT; Tang PH Acta Physiol (Oxf); 2018 Apr; 222(4):e13001. PubMed ID: 29178430 [TBL] [Abstract][Full Text] [Related]
11. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1. Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262 [TBL] [Abstract][Full Text] [Related]
12. Progesterone up-regulates p27 through an increased binding of the progesterone receptor-A-p53 protein complex onto the non-canonical p53 binding motif in HUVEC. Hsu SP; Lin PH; Chou CM; Lee WS J Steroid Biochem Mol Biol; 2019 Jan; 185():163-171. PubMed ID: 30145226 [TBL] [Abstract][Full Text] [Related]
13. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
14. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53. Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035 [TBL] [Abstract][Full Text] [Related]
15. Role of p21 as a determinant of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl] diamantane response in human HCT-116 colon carcinoma cells. Wang JJ; Hung HF; Huang ML; Lee HJ; Chern YT; Chang YF; Chi CW; Hsu YC Oncol Rep; 2012 Feb; 27(2):529-34. PubMed ID: 22076474 [TBL] [Abstract][Full Text] [Related]
16. Baicalein Inhibits Proliferation Activity of Human Colorectal Cancer Cells HCT116 Through Downregulation of Ezrin. Chen Z; Hou R; Gao S; Song D; Feng Y Cell Physiol Biochem; 2018; 49(5):2035-2046. PubMed ID: 30244250 [TBL] [Abstract][Full Text] [Related]
17. Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone. Wei M; He Q; Yang Z; Wang Z; Zhang Q; Liu B; Gu Q; Su L; Yu Y; Zhu Z; Zhang G BMC Cancer; 2014 Jan; 14():10. PubMed ID: 24401087 [TBL] [Abstract][Full Text] [Related]
18. Intracellular Progesterone Receptor and cSrc Protein Working Together to Regulate the Activity of Proteins Involved in Migration and Invasion of Human Glioblastoma Cells. Bello-Alvarez C; Moral-Morales AD; González-Arenas A; Camacho-Arroyo I Front Endocrinol (Lausanne); 2021; 12():640298. PubMed ID: 33841333 [TBL] [Abstract][Full Text] [Related]
19. Yeast-Derived Recombinant Avenanthramides Inhibit Proliferation, Migration and Epithelial Mesenchymal Transition of Colon Cancer Cells. Finetti F; Moglia A; Schiavo I; Donnini S; Berta GN; Di Scipio F; Perrelli A; Fornelli C; Trabalzini L; Retta SF Nutrients; 2018 Aug; 10(9):. PubMed ID: 30149546 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo studies of the anticancer action of terbinafine in human cancer cell lines: G0/G1 p53-associated cell cycle arrest. Lee WS; Chen RJ; Wang YJ; Tseng H; Jeng JH; Lin SY; Liang YC; Chen CH; Lin CH; Lin JK; Ho PY; Chu JS; Ho WL; Chen LC; Ho YS Int J Cancer; 2003 Aug; 106(1):125-37. PubMed ID: 12794767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]